Retatrutide 10mg

550.00

+ Free Shipping

KEY FEATURES

  • Form: Lyophilised peptide powder in a sterile vial
  • Active Compound: Retatrutide (triple receptor agonist)
  • Receptor Profile: GLP‑1, GIP, and glucagon receptor agonist
  • Concentration: 10 mg total peptide content per vial
  • Brand: Deus Medical
  • Package Content: 1 box containing 1 vial (10 mg total)
  • Also Known As: Retatrutide (GLP‑1 / GIP / Glucagon triple agonist, 10mg/vial)

BENEFITS

  • Triple-Pathway Design: Allows research into combined GLP‑1, GIP, and glucagon receptor activation within a single peptide structure.
  • Weekly-Orientated Pharmacokinetics: Approximate seven‑day half-life supports once-weekly protocol design.
  • Flexible Dosing Set-up: 10 mg vial format permits preparation of customised concentrations after reconstitution, depending on study needs.
  • Research Alignment: Suitable for projects exploring body weight regulation and appetite signalling under controlled conditions.

RETATRUTIDE 10 (GLP‑1, GIP Glucagon Triple Receptor Agonist) – Lyophilised Peptide Vial

PRODUCT OVERVIEW

RETATRUTIDE 10mg is a lyophilised peptide vial that functions as a triple receptor agonist. It targets three separate pathways: GLP-1 (Glucagon-like peptide-1), GIP (Glucose-dependent insulinotropic polypeptide), and glucagon. This multi-pathway approach supports insulin secretion, helps manage blood glucose levels, curbs appetite and craving pangs, and increases metabolism. It is ideal for structured programmes regarding body composition and glucose control. If you’re looking for Retatrutide online sale options,

Shopping Basket